TH and Parkinson disease: For instance, in an LPS-induced PD model in rats, BBG treatment reversed the reduction of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the substantia nigra by inhibiting the P38MAPK pathway, highlighting the neuroprotective effects of P2X7R antagonism (Wang et al., 2017).